Login to Your Account

FDA approves Anacor's first drug, Kerydin, for onychomycosis

By Michael Fitzhugh
Staff Writer

Tuesday, July 8, 2014
Anacor Pharmaceuticals Inc. on Tuesday won earlier-than-expected FDA approval for its first drug, Kerydin (tavaborole), a topical antifungal for the treatment of the common toenail and nail bed infection onychomycosis.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription